{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "I",
          "alt": "T",
          "position": "2020"
        },
        "variant_string_id": "LRRK2 I2020T"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Leucine-rich repeat kinase 2 (LRRK2) is the causal gene for autosomal dominant familial Parkinsonâ€™s disease. The I2020T mutation in LRRK2 is associated with higher susceptibility to intracellular degradation and impaired protectivity against apoptosis.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism relevant to the LRRK2 gene and its role in Parkinson's disease, particularly the effect of the I2020T mutation on protein degradation and apoptosis."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study used biochemical assays, including Western blotting, apoptosis assays, and cell viability assays to assess the functional impact of the I2020T LRRK2 mutation.",
          "judgment": "Yes",
          "reasoning": "These assays effectively model the disease pathogenesis by evaluating protein stability, cell death mechanisms, and cellular response to oxidative stress, which are relevant to Parkinson's disease.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "judgment": "Yes",
          "reasoning": "The paper describes the use of appropriate controls and replicates in the assays, making the functional evidence valid for further evaluation."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "sub_step_4a": {
            "step_name": "Sub-step 4a: Statistical Analyses",
            "extracted_paper_info": "The paper provides statistical comparisons using one-way ANOVA for the results of apoptosis assays and cell viability assays.",
            "judgment": "Yes",
            "reasoning": "Sufficient statistical analyses were performed to support the functional evidence.",
            "next_step_or_outcome": "Proceed to Sub-step 4c"
          },
          "sub_step_4c": {
            "step_name": "Sub-step 4c: Correlate OddsPath",
            "extracted_paper_info": "The paper does not directly provide an OddsPath value, but it shows that preventing intracellular degradation of I2020T LRRK2 restores its protective effect against apoptosis.",
            "judgment": "Yes",
            "reasoning": "The functional evidence suggests a strong impact on pathogenicity, as the protective effect of I2020T LRRK2 against apoptosis can be restored by preventing its intracellular degradation.",
            "next_step_or_outcome": "PS3_very_strong"
          }
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "The functional evidence strongly supports the pathogenicity of the I2020T LRRK2 variant, as demonstrated by the restoration of its protective effect against apoptosis when intracellular degradation is prevented. This suggests a new etiology of neurodegeneration in Parkinson's disease caused by the LRRK2 mutation."
    }
  ]
}